Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature reviews: Gastroenterology & hepatology

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/nrgastro.2017.119PMID 29018272PMCID PMC5899973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The microbiome and cancer

  2018cited by this paper
• High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization.

  2017cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Colorectal cancer statistics, 2017

  2017cited by this paper
• Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes

  2017cited by this paper
• Inflammatory bowel disease related innate immunity and adaptive immunity.

  2016cited by this paper
• Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.

  2016cited by this paper
• Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.

  2016cited by this paper
• Association between serum bile acid profiles and gestational diabetes mellitus: A targeted metabolomics study.

  2016cited by this paper
• The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer

  2016cited by this paper
• Regulation of immune cell function by short-chain fatty acids

  2016cited by this paper
• Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment.

  2016cited by this paper
• Distinctly altered gut microbiota in the progression of liver disease

  2016cited by this paper
• Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis

  2016cited by this paper
• Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice

  2016cited by this paper
• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

  2016cited by this paper
• Bile Acid Analog Intercepts Liver Fibrosis.

  2016cited by this paper
• Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.

  2016cited by this paper
• Intestinal transport and metabolism of bile acids

  2015cited by this paper
• Individual bile acids have differential effects on bile acid signaling in mice.

  2015cited by this paper
• Recent advances in the development of farnesoid X receptor agonists.

  2015cited by this paper
• New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.

  2015cited by this paper
• Tissue-specific actions of FXR in metabolism and cancer.

  2015cited by this paper
• TGR5 and Immunometabolism: Insights from Physiology and Pharmacology.

  2015cited by this paper
• The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.

  2015cited by this paper
• Two-step enzymatic synthesis of ursodeoxycholic acid with a new 7β-hydroxysteroid dehydrogenase from Ruminococcus torques

  2015cited by this paper
• The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics

  2015cited by this paper
• Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor–null mice by intestinal‐specific farnesoid X receptor reactivation

  2015cited by this paper
• Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases.

  2015cited by this paper
• Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis12

  2015cited by this paper
• Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease

  2014cited by this paper
• INTRACELLULAR SIGNALING BY BILE ACIDS

  2014cited by this paper
• Secondary bile acids: an underrecognized cause of colon cancer

  2014cited by this paper
• Targeted inhibition of the FGF19‐FGFR4 pathway in hepatocellular carcinoma; translational safety considerations

  2014cited by this paper
• Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes

  2014cited by this paper
• Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.

  2014cited by this paper
• Microbes, microbiota, and colon cancer.

  2014cited by this paper
• The bile acid TGR5 membrane receptor: from basic research to clinical application.

  2014cited by this paper
• FXR silencing in human colon cancer by DNA methylation and KRAS signaling.

  2014cited by this paper
• The cross talk between microbiota and the immune system: metabolites take center stage.

  2014cited by this paper
• Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands.

  2014cited by this paper
• Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

  2014cited by this paper
• Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases.

  2014cited by this paper
• Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency

  2014cited by this paper
• Bile Acid Signaling in Metabolic Disease and Drug Therapy

  2014cited by this paper
• The gut microbiota, bacterial metabolites and colorectal cancer

  2014cited by this paper
• The Role of Canalicular ABC Transporters in Cholestasis

  2014cited by this paper
• Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development

  2013cited by this paper
• Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

  2013cited by this paper
• Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.

  2013cited by this paper
• Melamine-Induced Renal Toxicity Is Mediated by the Gut Microbiota

  2013cited by this paper
• Bile acids PKA‐dependently induce a switch of the IL‐10/IL‐12 ratio and reduce proinflammatory capability of human macrophages

  2013cited by this paper
• Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

  2013cited by this paper
• Bile acids activate YAP to promote liver carcinogenesis.

  2013cited by this paper
• Metabolism of Cholesterol and Bile Acids by the Gut Microbiota

  2013cited by this paper
• Bile acid metabolism and signaling.

  2013cited by this paper
• Reference intervals for preprandial and postprandial serum bile acid in adult rhesus macaques (Macaca mulatta).

  2013cited by this paper
• Human gut microbiome and risk for colorectal cancer.

  2013cited by this paper
• Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

  2013cited by this paper
• FXR signaling in the enterohepatic system.

  2013cited by this paper
• The MDM2-p53 pathway revisited

  2013cited by this paper
• Tumour-associated macrophages and cancer.

  2013cited by this paper
• The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts*

  2013cited by this paper
• The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis

  2013cited by this paper
• Commensal bacteria at the interface of host metabolism and the immune system

  2013cited by this paper
• Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.

  2013cited by this paper
• A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

  2013cited by this paper
• Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

  2013cited by this paper
• Bile acid transporters and regulatory nuclear receptors in the liver and beyond

  2013cited by this paper
• Expression of bile acid receptor TGR5 in gastric adenocarcinoma.

  2013cited by this paper
• Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.

  2013cited by this paper
• TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease

  2013cited by this paper
• Bile acids in the colon, from healthy to cytotoxic molecules.

  2013cited by this paper
• Role of the gut microbiota in immunity and inflammatory disease

  2013cited by this paper
• Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia

  2013cited by this paper
• The microbiome and cancer

  2013cited by this paper
• Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease*

  2013cited by this paper
• Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle?

  2013cited by this paper
• Fusobacterium Is Associated with Colorectal Adenomas

  2013cited by this paper
• Inflammasome biology in fibrogenesis.

  2013cited by this paper
• A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids.

  2013cited by this paper
• Bile salts and their importance for drug absorption.

  2013cited by this paper
• Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility

  2013cited by this paper
• A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes

  2012cited by this paper
• Host-Gut Microbiota Metabolic Interactions

  2012cited by this paper
• Pleiotropic functions of bile acids mediated by the farnesoid X receptor.

  2012cited by this paper
• Novel insight into mechanisms of cholestatic liver injury.

  2012cited by this paper
• Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis

  2012cited by this paper
• INTRACELLULAR SIGNALING BY BILE ACIDS.

  2012cited by this paper
• Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method[S]

  2012cited by this paper
• Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

  2012cited by this paper
• Type and location of tumor‐infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients

  2012cited by this paper
• FAO/WHO guidelines on probiotics: 10 years later.

  2012cited by this paper
• Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model

  2012cited by this paper
• Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients.

  2012cited by this paper
• Therapeutic Modulation of Microbiota-Host Metabolic Interactions

  2012cited by this paper
• Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

  2012cited by this paper
• Genetic alterations in colorectal cancer.

  2012cited by this paper
• Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.

  2011cited by this paper
• Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice

  2011cited by this paper

• Targeting the gut microbiota: the application and prospects of probiotics, fecal microbiota transplantation, and natural products in MASLD

  2026cites this paper
• Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer

  2026cites this paper
• Bile acid profiles reflect metabolic adaptability to rapid weight loss in boxers.

  2026cites this paper
• The role of gut microbiota and its metabolites in preventing oncogenesis

  2026cites this paper
• Bile Acids as Key Mediators of the Gut Microbiota–Immune Axis: Potential Biomarker and Therapeutic Perspectives

  2026cites this paper
• Alterations in cardiovascular biomarkers and gut microbiome associated with night shift work: Insights from the Chinese Platform Workers Study.

  2026cites this paper
• Gut Microbiota-Mediated Molecular Events in Hepatocellular Carcinoma: From Pathogenesis to Treatment

  2026cites this paper
• Dietary Interventions With Schleiferilactobacillus harbinensis Z171, Its EPS and Postbiotics Ameliorate Cholesterol Metabolism via Modulating the Gut‐Liver Axis in High‐Fat Diet‐Fed Mice

  2026cites this paper
• Emerging Natural Products Against Obesity and MASLD/MASH: Direct Target Discovery and Mechanistic Insights

  2026cites this paper
• Multi-omics integration reveals the link between gut microbiota dysbiosis, host metabolic dysregulation, and aortic inflammation in abdominal aortic aneurysm​.

  2026cites this paper
• The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease

  2026cites this paper
• Non-invasive liquid biopsy based on metabolomic profiling improves diagnosis and early warning of severe acute pancreatitis

  2026cites this paper
• Bile resistance mechanisms in probiotics: From the molecular perspective

  2026cites this paper
• Electroacupuncture as a therapeutic intervention for obesity: mechanisms and implications

  2026cites this paper
• Role of gut microbiota metabolites in maintaining intestinal health and preventing weaning-associated diarrhea in piglets

  2026cites this paper
• Die primär sklerosierende Cholangitis als cholestatische Lebererkrankung und Modellerkrankung einer gestörten Darm-Leber-Achse

  2026cites this paper
• Microbiota–bile acid–host axis dysregulation drives enteropathogenesis in Escherichia coli K99-induced neonatal calf diarrhea

  2026cites this paper
• Interactions of bile acids and gut microbiota modulate neurological health: a comprehensive review on mechanisms and therapeutic potential of dietary phytochemicals.

  2026cites this paper
• Gut microbiota-derived deoxycholic acid mediates the exercise performance-potentiating efficacy of gypenosides.

  2026cites this paper
• From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

  2026cites this paper
• Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: Microbial-immune-metabolic network.

  2026cites this paper
• Multi-omics association investigation of the relationship between gut microbiota and the development of colorectal cancer.

  2026cites this paper
• Exploring the mechanism of Jianpi Guchang Recipe and Its Compound: Inhibition Liver Metastasis in Colorectal Carcinoma through regulation of the Bile Acid-FXR-FGF19 Axis.

  2026cites this paper
• Glycodeoxycholic acid inhibits hepatocellular carcinoma by driving M1 polarization of macrophages via the S1PR2-NF-κB-NLRP3 pathway

  2026cites this paper
• Ursodeoxycholic acid alleviates α-Casein-induced cow’s milk protein allergy via the TGR5/NF-κB signaling pathway

  2026cites this paper
• Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities.

  2026cites this paper
• Microbiota-metabolome interplay in depression: Metabolic insights and diagnostic potential

  2026cites this paper
• Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance.

  2026cites this paper
• Sulforaphane attenuates colitis-associated colorectal carcinogenesis: Dual modulation of Wnt/β-catenin signaling and gut microbial homeostasis in AOM/DSS models

  2026cites this paper
• FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities

  2026cites this paper
• Tamoxifen induced hepatotoxicity via gut microbiota-mediated hyodeoxycholic acid depletion and Farnesoid X receptor signaling disruption

  2026cites this paper
• Microbiome-Modulated Immunotherapy in Oncology: Current Applications and Future Prospects.

  2026cites this paper
• Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases.

  2026cites this paper
• A fast and reliable LC-QqQ-MS/MS analytical approach for the quantification of key bile acids in feces, serum, and liver: application to an intergenerational study

  2026cites this paper
• Nomogram Using Taurocholic Acid, Age, and Albumin to Predict HBV-Related Cirrhosis/HCC in CHB Patients

  2026cites this paper
• Prognostic and Diagnostic Value of Serum Bile Acid Profiles in Pancreatic Cancer: a Retrospective Multicenter Cohort Study

  2026cites this paper
• BSH, Bile Acids, and Barrier Function: Unlocking the Therapeutic Potential of Farnesoid X Receptor in the Pathogenesis of Colitis.

  2026cites this paper
• The mechanism of short-chain fatty acid in hypertriglyceridemic pancreatitis.

  2026cites this paper
• The interplay of dietary sugar, chronic inflammation, and bladder cancer: mechanistic insights, evidence, and prevention strategies.

  2026cites this paper
• The Gut Microbiota in Salmonella Typhi Infection and Translocation: Mechanisms of Colonization Resistance, Pathogen Subversion, and Prospects for Microecological Intervention.

  2026cites this paper
• Bruceine D ameliorates cholestatic liver injury by selectively modulating bile acid synthesis and activating FXR-SHP signaling.

  2026cites this paper
• 16S ribosomal ribonucleic acid sequencing reveals bile microbiome features in gallstone disease and their links to blood lipid subtypes.

  2026cites this paper
• GCDCA promotes hepatocellular carcinoma progression through S1PR2/PI3K/AKT-mediated polarization of M2-type macrophages

  2026cites this paper
• 10-Hydroxy-2(E)-decenoic Acid Attenuates Metabolic Dysfunction–Associated Steatotic Liver Disease via Modulation of the Gut Microbiota–Bile Acid–FXR Axis

  2026cites this paper
• Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction-associated steatotic liver disease.

  2026cites this paper
• Histological, ultrastructural, and single-cell profiling reveal immune-mediated remodeling in gallbladder inflammation.

  2026cites this paper
• Self-assembled Lentinus edodes ergosterol-amyloid fiber hydrogel for zebrafish enteritis mitigation: Role of intestinal flora regulation and metabolomic remodeling

  2026cites this paper
• Polyphenols and Probiotics Improve Mood Disorders by Regulating the Gut-Lung Axis

  2026cites this paper
• AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy.

  2026cites this paper
• Emerging mechanisms of microplastic-induced skin diseases: a perspective from the gut–skin axis

  2026cites this paper
• The gut-brain axis in diabetic neuropathy, cognitive impairment, and emotional disorders.

  2026cites this paper
• Integrated probiotic benefits of Limosilactobacillus fermentum PY-1 from the traditional fermented food "Suancai" drive antioxidant enhancement, immune protection, and gut microbiota regulation to attenuate autism-like behaviors in rats.

  2026cites this paper
• Oat β‐Glucan and Galactooligosaccharides Influence Gallstone Formation by Modulating the Gut Microbiota, Particularly Desulfovibrionales

  2026cites this paper
• Advances in Cholesterol Regulation by Lactobacillus : Technical Approaches, Mechanisms of Action, and Potential for Clinical Translation

  2026cites this paper
• Mechanistic insights into cholesterol–bile acid metabolic dysregulation in ovarian aging

  2026cites this paper
• Analysis of gut microbiota and intestinal secondary bile acids metabolism in rats after short-term antibiotic treatment.

  2026cites this paper
• A novel functional water significantly modulates the gut microbiota and decreases the basal level of inflammation in mice

  2026cites this paper
• Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanisms.

  2025cites this paper
• Cortex Dictamni induces cholestatic liver injury via the bile acid-gut-liver axis mediated by FXR signaling pathway in rats.

  2025cites this paper
• Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects.

  2025cites this paper
• A novel therapy targeting the gut–liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium

  2025cites this paper
• Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications.

  2025cites this paper
• Tributyltin Alters Seric Bile Acid Pool Composition in Male Rats

  2025cites this paper
• Beyond the tumor: the gut microbiome as a key player in immunotherapy efficacy and resistance

  2025cites this paper
• 2-Dodecyl-6-methoxycyclohexa-2,5-dien-1,4-dione alleviates liver fibrosis and improves intestinal flora and bile acid metabolism

  2025cites this paper
• Bile acid accumulation induced by miR-122 deficiency in liver parenchyma promotes cancer cell growth in hepatocellular carcinoma

  2025cites this paper
• Dietary bile acid supplementation improves the intestinal health and growth performance of piglets partially through the FXR/AQPs pathway

  2025cites this paper
• The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity

  2025influential citation
• Cholestasis in Alcohol-Associated Liver Disease

  2025influential citation
• Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention

  2025cites this paper
• Protective Effect of Obeticholic Acid on Sepsis-Induced Liver Dysfunction via Regulating Bile Acid Homeostasis

  2025cites this paper
• Dietary Manipulation on Gut Microbiome in Patients with Diabetes and Colorectal cancer

  2025cites this paper
• Integrated transcriptomic and metabolomic analyses reveal the mechanism by which quercetin inhibits reflux esophagitis in rats

  2025cites this paper
• LCA, a Bacterial Metabolite, Induces Ferroptosis and Senescence in Triple-Negative Breast Cancer.

  2025cites this paper
• Helicobacter pylori and Arsenic Co-exposure Intensify Gastric Barrier Damage and Serum Metabolic Disorder.

  2025cites this paper
• A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite-CerS6-ceramide axis.

  2025cites this paper
• Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5

  2025cites this paper
• Hyodeoxycholic Acid Ameliorates Metabolic Syndrome Through Pathways of Primary Bile Acid Synthesis and Fatty Acid Degradation: Insights From a Rat Model

  2025cites this paper
• New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites

  2025cites this paper
• Rhizome of Atractylodes macrocephala Alleviates Spleen-Deficiency Constipation in Rats by Modulating Gut Microbiota and Bile Acid Metabolism.

  2025cites this paper
• Targeting gut microbiota and its associated metabolites as a potential strategy for promoting would healing in diabetes

  2025cites this paper
• Acalabrutinib alleviates metabolic dysfunction-associated steatotic liver disease by regulating bile acid metabolism.

  2025cites this paper
• Polystyrene microplastics reduce honeybee survival by disrupting gut microbiota and metabolism.

  2025cites this paper
• Lactococcus petauri LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function

  2025cites this paper
• Gut microbiota regulates hepatic ketogenesis and lipid accumulation in ketogenic diet-induced hyperketonemia by disrupting bile acid metabolism

  2025cites this paper
• Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications.

  2025cites this paper
• Comparative analysis of gut microbiota-mediated bile acid profiles in Bufo gargarizans and Rana chensinensis tadpoles.

  2025cites this paper
• Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers

  2025cites this paper
• Suppressed intestinal secondary bile acids in moxifloxacin-induced hyperglycemia: studies in normal and diabetic GK rats

  2025cites this paper
• Regulatory effects of the bidirectional crosstalk between hepatic gene expressions and gut microbiota on the productive performances and egg quality of induced molting treated layer hens

  2025cites this paper
• The solid tumor microenvironment and related targeting strategies: a concise review

  2025cites this paper
• Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma

  2025cites this paper
• The Relationship of the Microbiome, Associated Metabolites and the Gut Barrier with Pancreatic Cancer.

  2025cites this paper
• The metabolites of gut microbiota: their role in ferroptosis in inflammatory bowel disease

  2025cites this paper
• Antioxidant and immunomodulator nanoengineered probiotics for synergistic therapy of inflammatory bowel disease

  2025cites this paper
• Use of consensus clustering to identify subtypes of clinical early-stage non-small cell lung cancer and its association with lymph node metastasis

  2025cites this paper
• Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies

  2025cites this paper
• Co-stimulation with high-fat diet and acidic bile salts may promote Warburg effect in gastric carcinogenesis around the squamo-columnar junction in Gan mice.

  2025cites this paper
• Multi-omics analysis reveals dynamic changes in gut microbiota and metabolites associated with cholecystectomy and post-cholecystectomy diarrhea

  2025cites this paper
• The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis

  2025cites this paper